These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1950942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P.
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM, de Wolf F, Krone WJ, Danner SA, Coutinho RA, Goudsmit J.
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Subjects infected with human immunodeficiency virus: serological markers of prognostic value].
    Hurtado C, Velasco M, Sepúlveda C.
    Rev Med Chil; 1989 Mar; 117(3):251-7. PubMed ID: 2488516
    [Abstract] [Full Text] [Related]

  • 16. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunoglobulin A and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts].
    Muga R, Tor J, Solsona L, Villanueva C, Pol M, Jacas C, Sabriá M, Rey-Joly C, Foz M.
    Med Clin (Barc); 1991 Mar 16; 96(10):361-3. PubMed ID: 2046411
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.